Digestive Stool Analysis

Digestive Stool Analysis

Genova Diagnostics – Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0) offers unique insight into overall and gastrointestinal health by assessing a combination of novel stool biomarkers.

This stool analysis evaluates:

  •  Digestion/Absorption Markers
  •  Immunology (Inflammation) Markers
  • Pancreatic Enzymes, assessment of pancreatic function Immunology (Inflammation) Markers
  • Calprotectin, an FDA-cleared biomarker that effectively differentiates between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
  • Gut Metabolic Markers
  • Gut Microbiology Markers
  • Gold standard O&P (ova & parasite) technology as well as EIA (Enzyme Immunoassay) for identification of common parasites

The Bacterial Overgrowth of the Small Intestine Breath Test (SIBO/BOSI) is appropriate for patients who demonstrate:

Irritable Bowel Syndrome (IBS), the most commonly diagnosed gastrointestinal disorder, affecting 20% of the general population. The SIBO test aids in identifying the actual cause of IBS.  Studies suggest that as many as 50-75% of patients with IBS have SIBO/BOSI, as demonstrated by hydrogen breath testing.

Unexplained abdominal symptoms, especially gas and bloating.

The inability to tolerate sweet or starchy foods, fiber, or friendly flora supplements.

For the past 15 years we provide solutions that other clinicians view impossible to solve